Surgical Robotics Market (By Component: Systems, Accessories, Services; By Surgery Type: Gynecology Surgery, Urology Surgery, Neurosurgery, Orthopedic Surgery, General Surgery, Other Surgeries; By End User: Hospitals, Ambulatory surgical centers )- Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2023 – 2032
The global surgical robotics market size was valued at USD 8 billion in 2022 and it is expected to surpass around USD 36.37 billion by 2032, growing at a CAGR of 16.4% during the forecast period 2023 to 2032.
Access our Healthcare Data Intelligence Tool with 10000+ Database, Visit: Towards Healthcare
In the 2022, the North American market had the largest revenue share of about 51%. The adoption of automated surgical instruments in the health care industry and the increasing health care facilities in the United States will drive the market in this region. The less number of healthcare professionals and surgeons in the US depending upon the patient population will also drive the regional market for surgical robots. Chronic illnesses like diabetes, cancer and the cardiovascular diseases have led to an acceleration growth of the market.
Growing population and increasing adoption of advanced automated surgical devices in the Asia Pacific region will help in the growth of the market. The adoption of advanced medical technology and avalability of modern health care infrastructure has led to a growth in the Asia Pacific region. Investors are investing in automated instruments and this is expected to help in the growth of the market. Growing awareness of robotics in surgery and the higher acceptance rate of the surgical robots in this region, the market is expected to grow.
The in availability of various surgeons and physicians across the globe is leading to an increase in adoption of automated instruments for surgery. The surgeries have evolved. Surgery has now involved the use of robots that are able to do the work with extreme precision compared to the humans. The surgeries with the use of surgical robots are able to provide precision in anatomical areas that are very difficult for human surgeons to perform. Surgical robots are made to solve the limitations in the invasive surgeries and surgical robots are adopted in order to improve the outcome of the open surgical procedures. Surgical robots are used in various areas including cardiovascular, orthopedics, neurosurgery, general surgery, gynecology and obstetrics. The robots used in surgical market are extraordinarily structured in order to have access to various surgeries without making a large incision which normal specialist would do. The medical centers will be able to deliver high quality operations due to the use of robot assisted surgery procedures ever since the product has been introduced in the market that has been a rapid growth.
The surgical robotic market is expected to grow due to the increasing geriatric population, technological improvements, and the increased focus on the robotics training provided to the doctors. There shall be great innovation in the robotics space due to adoption of technologies like artificial intelligence and cloud computing, which will help in improving the output and reducing the workload for the humans. As there is an increase in the demand and acceptance of the laparoscopic or the minimally invasive surgeries. The market for surgical robots is expected to grow. Since the patients are aware of the benefits of such surgeries. They opt for this kind of a surgery. It provides great precision, better screening, shorter hospitalization time, reduced risk of infection, reduced pain and discomfort and reduced blood flow.
Owing to an increase in demand for advanced robotic surgeries and automation in the healthcare industry, the surgical robotics market is expected to grow during the forecast period. With the ongoing research and development, there will be an introduction of new sophisticated robots which will help in meeting the growing needs of the end users. Increased accidents and the injuries caused by these accidents shall impede the growth of the surgical robot's market. The developing nations like Brazil, China and India shall also provide good growth opportunities for the surgical robotics market. Several industrial strategic initiatives which are taken by the international players will help in the market growth over the years. It will help in the adoption of robots during the forecast. Integration of cameras or high definition 3D imaging sensors, remote navigation systems or computing technologies in the robots will help in increasing the adoption of robots in the Surgeries.
| Report Coverage | Details |
| Market Size in 2023 | USD 9.27 Billion |
| Market Size by 2032 | USD 36.37 Billion |
| Growth Rate from 2023 to 2032 | CAGR of 16.4% |
| Largest Market | North America |
| Fastest Growing Market | Asia Pacific |
| Base Year | 2022 |
| Forecast Period | 2023 to 2032 |
| Segments Covered | Component, Surgery Type, End User, Geography |
| Companies Mentioned | Medrobotics, Renishaw plc., TransEnterix Surgical, Inc., Intuitive Surgical, Medtronic plc., THINK Surgical Inc., Zimmer Biomet Holdings Inc., Smith & Nephew Plc. (Blue Belt Technologies, Inc.), Auris Surgical Robotics, Inc. (Hansen Medical Inc.), Intuitive Surgical, Inc., KUKA AG, Stryker, orporation (MAKO Surgical Corp.), Mazor Robotics |
On the basis of the surgery the surgical robotics market is bifurcated into urology surgery, gynecology surgery, neurosurgery, general surgery, orthopedic surgery and other surgeries. The Neurosurgery segment is expected to grow at the fastest rate during the forecast. There is great amount of adoption of robots in neuro surgeries over the traditional techniques. Technological advancements and the use of robots in neuro Surgeries have successful outcomes. The use of automated robotic instruments in brain surgeries will help in the growth of the market. The orthopedic Surgery segment has the good position in the market as there are many injuries caused due to bike and road accidents or any other accidents that need surgeries. Arthritis, joint pains and other reasons for correcting the bones are expected to help in the growth of the market. There's an increased use of robotics for treatment of cancer. For minimally invasive laparoscopic surgeries the demand for robotics has increased in the recent years.
The component segment is bifurcated into systems, accessories and services. The accessory segment has dominated the global surgical robotics market due to an extensive use of accessories for the surgical procedures. The Services segment is also expected to grow well due to a rise in the robot assisted surgeries across the nations. Increase in the geriatric populationand chronic diseases like diabetes, arthritis and HIV AIDS leads to the growing use of robots.
On the basis of the end user, the surgical robotics market is expected to grow in the hospital segment. In the coming years, there shall be an increase in the demand for surgical reports at various hospitals settings and it will offer a lucrative market growth. Surgical robots at the hospital settings will be able to help with effective patient care. The high amount of inpatient visits and increasing surgical procedures at the hospital will lead to the growth in the market. Larger and better hospital infrastructure along with the skilled healthcare personnel available at this infrastructure will help in changing the scenario in various emerging economies.
(Note*: We offer report based on sub segments as well. Kindly, let us know if you are interested)
By Component
By Surgery Type
By End User
By Geography
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Surgical Robotics Market
5.1. COVID-19 Landscape: Surgical Robotics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Surgical Robotics Market, By Component
8.1. Surgical Robotics Market, by Component, 2023-2032
8.1.1 Systems
8.1.1.1. Market Revenue and Forecast (2021-2032)
8.1.2. Accessories
8.1.2.1. Market Revenue and Forecast (2021-2032)
8.1.3. Services
8.1.3.1. Market Revenue and Forecast (2021-2032)
Chapter 9. Global Surgical Robotics Market, By Surgery Type
9.1. Surgical Robotics Market, by Surgery Type, 2023-2032
9.1.1. Gynecology Surgery
9.1.1.1. Market Revenue and Forecast (2021-2032)
9.1.2. Urology Surgery
9.1.2.1. Market Revenue and Forecast (2021-2032)
9.1.3. Neurosurgery
9.1.3.1. Market Revenue and Forecast (2021-2032)
9.1.4. Orthopedic Surgery
9.1.4.1. Market Revenue and Forecast (2021-2032)
9.1.5. General Surgery
9.1.5.1. Market Revenue and Forecast (2021-2032)
9.1.6. Other Surgeries
9.1.6.1. Market Revenue and Forecast (2021-2032)
Chapter 10. Global Surgical Robotics Market, By End User
10.1. Surgical Robotics Market, by End User, 2023-2032
10.1.1. Hospitals
10.1.1.1. Market Revenue and Forecast (2021-2032)
10.1.2. Ambulatory surgical centers
10.1.2.1. Market Revenue and Forecast (2021-2032)
Chapter 11. Global Surgical Robotics Market, Regional Estimates and Trend Forecast
11.1. North America
11.1.1. Market Revenue and Forecast, by Component (2021-2032)
11.1.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.1.3. Market Revenue and Forecast, by End User (2021-2032)
11.1.4. U.S.
11.1.4.1. Market Revenue and Forecast, by Component (2021-2032)
11.1.4.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.1.4.3. Market Revenue and Forecast, by End User (2021-2032)
11.1.5. Rest of North America
11.1.5.1. Market Revenue and Forecast, by Component (2021-2032)
11.1.5.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.1.5.3. Market Revenue and Forecast, by End User (2021-2032)
11.2. Europe
11.2.1. Market Revenue and Forecast, by Component (2021-2032)
11.2.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.2.3. Market Revenue and Forecast, by End User (2021-2032)
11.2.4. UK
11.2.4.1. Market Revenue and Forecast, by Component (2021-2032)
11.2.4.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.2.4.3. Market Revenue and Forecast, by End User (2021-2032)
11.2.5. Germany
11.2.5.1. Market Revenue and Forecast, by Component (2021-2032)
11.2.5.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.2.5.3. Market Revenue and Forecast, by End User (2021-2032)
11.2.6. France
11.2.6.1. Market Revenue and Forecast, by Component (2021-2032)
11.2.6.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.2.6.3. Market Revenue and Forecast, by End User (2021-2032)
11.2.7. Rest of Europe
11.2.7.1. Market Revenue and Forecast, by Component (2021-2032)
11.2.7.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.2.7.3. Market Revenue and Forecast, by End User (2021-2032)
11.3. APAC
11.3.1. Market Revenue and Forecast, by Component (2021-2032)
11.3.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.3.3. Market Revenue and Forecast, by End User (2021-2032)
11.3.4. India
11.3.4.1. Market Revenue and Forecast, by Component (2021-2032)
11.3.4.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.3.4.3. Market Revenue and Forecast, by End User (2021-2032)
11.3.5. China
11.3.5.1. Market Revenue and Forecast, by Component (2021-2032)
11.3.5.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.3.5.3. Market Revenue and Forecast, by End User (2021-2032)
11.3.6. Japan
11.3.6.1. Market Revenue and Forecast, by Component (2021-2032)
11.3.6.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.3.6.3. Market Revenue and Forecast, by End User (2021-2032)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue and Forecast, by Component (2021-2032)
11.3.7.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.3.7.3. Market Revenue and Forecast, by End User (2021-2032)
11.4. MEA
11.4.1. Market Revenue and Forecast, by Component (2021-2032)
11.4.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.4.3. Market Revenue and Forecast, by End User (2021-2032)
11.4.4. GCC
11.4.4.1. Market Revenue and Forecast, by Component (2021-2032)
11.4.4.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.4.4.3. Market Revenue and Forecast, by End User (2021-2032)
11.4.5. North Africa
11.4.5.1. Market Revenue and Forecast, by Component (2021-2032)
11.4.5.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.4.5.3. Market Revenue and Forecast, by End User (2021-2032)
11.4.6. South Africa
11.4.6.1. Market Revenue and Forecast, by Component (2021-2032)
11.4.6.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.4.6.3. Market Revenue and Forecast, by End User (2021-2032)
11.4.7. Rest of MEA
11.4.7.1. Market Revenue and Forecast, by Component (2021-2032)
11.4.7.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.4.7.3. Market Revenue and Forecast, by End User (2021-2032)
11.5. Latin America
11.5.1. Market Revenue and Forecast, by Component (2021-2032)
11.5.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.5.3. Market Revenue and Forecast, by End User (2021-2032)
11.5.4. Brazil
11.5.4.1. Market Revenue and Forecast, by Component (2021-2032)
11.5.4.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.5.4.3. Market Revenue and Forecast, by End User (2021-2032)
11.5.5. Rest of LATAM
11.5.5.1. Market Revenue and Forecast, by Component (2021-2032)
11.5.5.2. Market Revenue and Forecast, by Surgery Type (2021-2032)
11.5.5.3. Market Revenue and Forecast, by End User (2021-2032)
Chapter 12. Company Profiles
12.1. Medrobotics
12.1.1. Company Overview
12.1.2. Product Offerings
12.1.3. Financial Performance
12.1.4. Recent Initiatives
12.2. Renishaw plc
12.2.1. Company Overview
12.2.2. Product Offerings
12.2.3. Financial Performance
12.2.4. Recent Initiatives
12.3. TransEnterix Surgical, Inc.
12.3.1. Company Overview
12.3.2. Product Offerings
12.3.3. Financial Performance
12.3.4. Recent Initiatives
12.4. Intuitive Surgical
12.4.1. Company Overview
12.4.2. Product Offerings
12.4.3. Financial Performance
12.4.4. Recent Initiatives
12.5. Medtronic plc.
12.5.1. Company Overview
12.5.2. Product Offerings
12.5.3. Financial Performance
12.5.4. Recent Initiatives
12.6. THINK Surgical Inc.
12.6.1. Company Overview
12.6.2. Product Offerings
12.6.3. Financial Performance
12.6.4. Recent Initiatives
12.7. Zimmer Biomet Holdings Inc.
12.7.1. Company Overview
12.7.2. Product Offerings
12.7.3. Financial Performance
12.7.4. Recent Initiatives
12.8. Smith & Nephew Plc. (Blue Belt Technologies, Inc.)
12.8.1. Company Overview
12.8.2. Product Offerings
12.8.3. Financial Performance
12.8.4. Recent Initiatives
12.9. Auris Surgical Robotics, Inc. (Hansen Medical Inc.)
12.9.1. Company Overview
12.9.2. Product Offerings
12.9.3. Financial Performance
12.9.4. Recent Initiatives
12.10. Intuitive Surgical, Inc.
12.10.1. Company Overview
12.10.2. Product Offerings
12.10.3. Financial Performance
12.10.4. Recent Initiatives
Chapter 13. Research Methodology
13.1. Primary Research
13.2. Secondary Research
13.3. Assumptions
Chapter 14. Appendix
14.1. About Us
14.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
